| Aug 28 |
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
|
| Aug 28 |
Kohl's Posts Upbeat Q2 Earnings, Joins Box, Waldencast, AeroVironment And Other Big Stocks Moving Higher On Wednesday
|
| Aug 28 |
3 High-Yield Dividend Stocks With Payout Ratios Below 75%
|
| Aug 28 |
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
|
| Aug 27 |
Market Whales and Their Recent Bets on BMY Options
|
| Aug 26 |
Bristol Myers Squibb to Present Data Across Cardiovascular Portfolio at the European Society of Cardiology Congress 2024
|
| Aug 23 |
Cancer Medicines From Merck, Bristol Myers And BeiGene In Question, As FDA Committee To Discuss Limiting PD-1 Drugs For Stomach Cancer
|
| Aug 23 |
Merck, Bristol Myers cancer drugs included in September FDA advisory panel meeting
|
| Aug 22 |
Bristol Myers' HCC Combo Drug Accepted for FDA Review
|
| Aug 22 |
Bristol Myers' (BMY) HCC Combo Drug Accepted for FDA Review
|
